anti-TNFRSF10D (TNFRSF10D) Antikörper

Bezeichnung:
anti-Tumor Necrosis Factor Receptor Superfamily, Member 10d, Decoy with Truncated Death Domain Antikörper (TNFRSF10D)
Auf www.antikoerper-online.de finden Sie aktuell 216 Tumor Necrosis Factor Receptor Superfamily, Member 10d, Decoy with Truncated Death Domain (TNFRSF10D) Antikörper von 24 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen TNFRSF10D Proteine (19) und TNFRSF10D Kits (9) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 254 TNFRSF10D Produkte verfügbar.
Synonyme:
CD264, DCR2, TNFRSF10D, TRAIL-R4, TRAILR4, TRUNDD
Alle Antikörper anzeigen Gen GeneID UniProt
TNFRSF10D 8793 Q9UBN6
TNFRSF10D    
TNFRSF10D    

Alle Spezies anzeigen

Weitere Synonyme anzeigen

Meistgesuchte Reaktivitäten zu anti-TNFRSF10D (TNFRSF10D) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human TNFRSF10D Antikörper:

anti-Mouse (Murine) TNFRSF10D Antikörper:

anti-Rat (Rattus) TNFRSF10D Antikörper:

Alle verfügbaren anti-TNFRSF10D Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-TNFRSF10D Antikörper

  1. Human Monoclonal TNFRSF10D Primary Antibody für ELISA (Capture), FACS - ABIN4900417 : Barbarotto, Corallini, Rimondi, Fadda, Mischiati, Grill, Vaccarezza, Celeghini: Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. in Journal of cellular biochemistry 2008 (PubMed)
    Zeige alle 12 Referenzen für 4900417

  2. Human Monoclonal TNFRSF10D Primary Antibody für FACS - ABIN4897669 : Stary, Klein, Kohlhofer, Koszik, Scherzer, Müllauer, Quendler, Kohrgruber, Stingl: Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients. in Blood 2009 (PubMed)
    Zeige alle 7 Referenzen für 4897669

  3. Human Polyclonal TNFRSF10D Primary Antibody für FACS, IHC - ABIN4900418 : Zauli, Pandolfi, Gonelli, Di Pietro, Guarnieri, Ciabattoni, Rana, Vitale, Secchiero: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. in Circulation research 2003 (PubMed)
    Zeige alle 6 Referenzen für 4900418

  4. Human Monoclonal TNFRSF10D Primary Antibody für FACS - ABIN487316 : Mérino, Lalaoui, Morizot, Schneider, Solary, Micheau: Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. in Molecular and cellular biology 2006 (PubMed)
    Zeige alle 5 Referenzen für 487316

  5. Human Monoclonal TNFRSF10D Primary Antibody für FACS - ABIN487317 : Deligezer, Dalay: Expression of the TRAIL receptors in blood mononuclear cells in leukemia. in Pathology oncology research : POR 2007 (PubMed)
    Zeige alle 5 Referenzen für 487317

  6. Human Polyclonal TNFRSF10D Primary Antibody für EIA, FACS - ABIN951252 : Pei, Wu, Lin: Hypoxia-induced decoy receptor 2 gene expression is regulated via a hypoxia-inducible factor 1alpha-mediated mechanism. in Biochemical and biophysical research communications 2010 (PubMed)
    Zeige alle 2 Referenzen für 951252

  7. Human Monoclonal TNFRSF10D Primary Antibody für FACS - ABIN1106174 : Baritaki, Katsman, Chatterjee, Yeung, Spandidos, Bonavida: Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. in Journal of immunology (Baltimore, Md. : 1950) 2007 (PubMed)
    Zeige alle 2 Referenzen für 1106174

  8. Human Monoclonal TNFRSF10D Primary Antibody für ELISA, IHC (p) - ABIN1996725 : Meng, McDonald, Sheikh, Fornace, El-Deiry: The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis. in Molecular therapy : the journal of the American Society of Gene Therapy 2000 (PubMed)

Weitere Antikörper gegen TNFRSF10D Interaktionspartner

Human Tumor Necrosis Factor Receptor Superfamily, Member 10d, Decoy with Truncated Death Domain (TNFRSF10D) Interaktionspartner

  1. Urinary DcR2 (zeige CCR6 Antikörper) could potentially serve as a novel biomarker for tubulointerstitial injury and may reflect senescence of renal proximal tubular cells in diabetic nephropathy.

  2. Results identified epigenetic inactivation of TNFRSF10C (zeige TNFRSF10C Antikörper) and TNFRSF10D in majority of cervical cancer cases.

  3. This study identified TNFRSF10D DNA methylation (zeige HELLS Antikörper) status as an independent prognostic biomarker for relapse-free survival and overall mortality in non-metastatic melanoma patients.

  4. The membrane expression of the TRAIL receptors DR4 (zeige HLADRB4 Antikörper), DR5 (zeige TNFRSF10B Antikörper), DcR1 (zeige TNFRSF10C Antikörper) and DcR2 (zeige CCR6 Antikörper) is greater in normal endometrium than endometrioid adenocarcinoma (EAC (zeige CYLD Antikörper)). The level of the receptors in EAC (zeige CYLD Antikörper) is not dependent on grading and staging and does not predict survival.

  5. the results presented here claim for a relevant impact of aberrant methylation of decoy receptors in melanoma and allow to understand how the silencing of DcR1 (zeige TNFRSF10C Antikörper) and DcR2 (zeige CCR6 Antikörper) is related to melanomagenesis.

  6. transcript levels of UCHL1 (zeige UCHL1 Antikörper), COL1A2 (zeige COL1A2 Antikörper), THBS1 (zeige THBS1 Antikörper) and TNFRSF10D were inversely correlated with promoter methylation

  7. TRAIL receptor-4 expression profiles on T cells might be important in revelation of rheumatoid arthritis pathogenesis.

  8. ANT2 (zeige SLC25A5 Antikörper) shRNA treatment sensitized MCF7, T47 D, and BT474 cells to TRAIL-induced apoptosis by up-regulating the expression of TRAIL death receptors 4 and 5 (DR4 (zeige HLADRB4 Antikörper) and DR5 (zeige TNFRSF10B Antikörper)) and down-regulating the TRAIL decoy receptor 2 (DcR2).

  9. these results demonstrated that hypoxia-inducible factor 1alpha played a crucial role in regulating the transcription of DcR2 (zeige CCR6 Antikörper).

  10. TNF-related apoptosis-inducing ligand (TRAIL (zeige TNFSF10 Antikörper)) is not constitutively expressed in the human brain, whereas both apoptosis-mediating and apoptosis-blocking TRAIL receptors are found on neurons, astrocytes, and oligodendrocytes

TNFRSF10D Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain, a transmembrane domain, and a truncated cytoplamic death domain. This receptor does not induce apoptosis, and has been shown to play an inhibitory role in TRAIL-induced cell apoptosis.

Alternative names and synonyms associated with TNFRSF10D

  • tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain (TNFRSF10D) Antikörper
  • CD264 Antikörper
  • DCR2 Antikörper
  • TNFRSF10D Antikörper
  • TRAIL-R4 Antikörper
  • TRAILR4 Antikörper
  • TRUNDD Antikörper

Bezeichner auf Proteinebene für TNFRSF10D

tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain , TNF receptor-related receptor for TRAIL , TNF-related apoptosis-inducing ligand receptor 4 , TRAIL receptor 4 , TRAIL receptor with a truncated death domain , decoy receptor 2 , tumor necrosis factor receptor superfamily member 10D

GENE ID SPEZIES
472715 Pan troglodytes
716901 Macaca mulatta
8793 Homo sapiens
Ausgewählte Anbieter für anti-TNFRSF10D (TNFRSF10D) Antikörper
Haben Sie etwas anderes gesucht?